Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting the replication stress response through synthetic lethal strategies in cancer medicine

Trends in cancer(2021)10.1016/j.trecan.2021.06.002Source: DataRank Database

Targeting the replication stress response through synthetic lethal strategies in cancer medicine is a research paper published in Trends in cancer (2021). On theSindex it has a DataRank of 0. It has been cited 95 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access95 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: greenTopics (21)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Melissa Pham,David S.P. Tan ORCID,Timothy A. Yap ORCID,Natalie Y.L. Ngoi ORCID

Live enrichment

PubMed:34215565 PMC:PMC8458263

National Cancer Institute

Grant: P30 CA016672

National Medical Research Council

Grant: CSAINV16may008

National Medical Research Council

Grant: MOH-FLWSHP19may-0006

NCATS NIH HHS

Grant: UL1 TR003167

NCI NIH HHS

Grant: T32 CA101642

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

EMD Serono

GlaxoSmithKline

AstraZeneca

Meso Scale Diagnostics

Ipsen

Janssen Pharmaceuticals

Bayer Fund

National Institutes of Health

Genentech

University of Texas MD Anderson Cancer Center

Novartis

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8458263

publisherhttps://api.elsevier.com/content/article/PII:S2405803321001230?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803321001230?httpAccept=text/plain

https://doi.org/10.1016/j.trecan.2021.06.002

https://pubmed.ncbi.nlm.nih.gov/34215565

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNeoplasmsAtaxia Telangiectasia Mutated ProteinsPoly(ADP-ribose) Polymerase InhibitorsCheckpoint Kinase 1Synthetic Lethal Mutations

Keywords

Combination therapySynthetic LethalityReplicative Stress ResponseParp Inhibition ResistanceNeoplasmsCheckpoint Kinase 1610HumansAtaxia Telangiectasia Mutated Proteins613Poly(ADP-ribose) Polymerase InhibitorsSynthetic Lethal Mutations

Sustainable Development Goals

SDG 3: 3. Good health

Targeting the replication stress response through synthetic lethal strategies in cancer medicine

FAIR Checklist

Authors (4)

Funding (17 grants)

Open Access

Topics

Annotations (Europe PMC)